Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
Aram J. Krauson, Faye Victoria C. Casimero, Zakir Siddiquee, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

DNA Vaccines: Their Formulations, Engineering and Delivery
Michael Kozak, Jiafen Hu
Vaccines (2024) Vol. 12, Iss. 1, pp. 71-71
Open Access | Times Cited: 29
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
Molecular Therapy (2025) Vol. 33, Iss. 3, pp. 1105-1117
Open Access | Times Cited: 1
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
Unraveling Links between Chronic Inflammation and Long COVID: Workshop Report
Pushpa Tandon, Natalie Abrams, Leela Rani Avula, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 4, pp. 505-512
Open Access | Times Cited: 11
The mRNA-LNP vaccines – the good, the bad and the ugly?
Botond Z. Igyártó, Zhen Qin
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70
Byron Brook, Valérie Duval, Soumik Barman, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 757
Closed Access | Times Cited: 9
Long‐lasting, biochemically modified mRNA, and its frameshifted recombinant spike proteins in human tissues and circulation after COVID‐19 vaccination
László G. Boros, Anthony M. Kyriakopoulos, Carlo Brogna, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 8
Biodistribution of RNA Vaccines and of Their Products: Evidence from Human and Animal Studies
Ildus Pateev, Kristina Seregina, Roman Ivanov, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 59-59
Open Access | Times Cited: 19
Post-SARS-CoV-2 infection and post-vaccine-related neurological complications share clinical features and the same positivity to anti-ACE2 antibodies
Margherita Bellucci, Federica Bozzano, Chiara Castellano, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans
Stephen J. Kent, Shiyao Li, Thakshila Amarasena, et al.
ACS Nano (2024)
Open Access | Times Cited: 6
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
Targeting vaccines to dendritic cells by mimicking the processing and presentation of antigens in xenotransplant rejection
Jinjin Wang, Yuxuan Zhang, Yaru Jia, et al.
Nature Biomedical Engineering (2025)
Closed Access
Preclinical Evaluation of the RBD-Trimeric Vaccine: A Novel Approach to Strengthening Biotechnological Sovereignty in Developing Countries Against SARS-CoV-2 Variants.
Luis Flórez, Daniel Echeverri-De la Hoz, Alfonso Calderón, et al.
Travel Medicine and Infectious Disease (2025), pp. 102820-102820
Open Access
Risk stratification for future cardiac arrest after COVID-19 vaccination
Peter A McCullough, Nicolas Hulscher
World Journal of Cardiology (2025) Vol. 17, Iss. 2
Closed Access
Blood donor SARS‐CoV‐2 infection or vaccination and adverse outcomes in plasma and platelet transfusion recipients
Nareg H. Roubinian, J Greene, Bryan R. Spencer, et al.
Transfusion (2025)
Closed Access
Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections
Carla Martín Pérez, Sílvia Ruiz-Rius, Anna Ramírez‐Morros, et al.
Journal of Infection (2025), pp. 106473-106473
Open Access
Immunization-induced antigen archiving enhances local memory CD8+ T cell responses following an unrelated viral infection
Thu A. Doan, Tadg Forward, Johnathon Schafer, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19
David Scheim, Paola Vottero, Alessandro D. Santin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17039-17039
Open Access | Times Cited: 11
Progress with COVID vaccine development and implementation
Richard W. Titball, David I. Bernstein, Nicolas V. J. Fanget, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
β-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model
Anna Laura Nelson, Chiara Mancino, Xueqin Gao, et al.
Bioactive Materials (2024) Vol. 39, pp. 273-286
Open Access | Times Cited: 3
Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington
Nicolas Hulscher, Michael J. Cook, Raphael B. Stricker, et al.
(2024)
Open Access | Times Cited: 3
Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates
Maureen Buckley, Mariluz Araínga, Laura Maiorino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
SARS-CoV2 mRNA vaccine intravenous administration induces myocarditis in chronic inflammation
Haeun Jeon, Seonghyun Lee, Jisun Lee, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0311726-e0311726
Open Access | Times Cited: 3
Response to: Van Wyk et al. letter to the editor regarding ‘Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis’
Nicolas Hulscher, Roger Hodkinson, William Makis, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 4, pp. 2476-2478
Open Access | Times Cited: 2
Sputnik V-induced Antibodies against SARS-CoV-2 Variants during the Dissemination of the Gamma Variant in Venezuela
Christopher Franco, Alejandro Cornejo, Mariajosé Rodríguez, et al.
(2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top